Omega Fund V, L.P.'s Net Worth
$242 Million
Who is Omega Fund V, L.P.?
Omega Fund V, L.P. has an estimated net worth of $242 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Morphic Holding, Inc., IMMUNIC, INC., Gossamer Bio, Inc., Kronos Bio, Inc., Translate Bio, Inc., and Trevi Therapeutics, Inc..
SEC CIK
Omega Fund V, L.P.'s CIK is 0001641354
Past Insider Trading and Trends
2019 was Omega Fund V, L.P.'s most active year for acquiring shares with 5 total transactions. Omega Fund V, L.P.'s most active month to acquire stocks was the month of September. 2021 was Omega Fund V, L.P.'s most active year for disposing of shares, totalling 208 transactions. Omega Fund V, L.P.'s most active month to dispose stocks was the month of March. 2020 saw Omega Fund V, L.P. paying a total of $14,465,728.85 for 3,798,832 shares, this is the most they've acquired in one year. In 2021 Omega Fund V, L.P. cashed out on 14,237,949 shares for a total of $92,064,268.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.89% | -2.50M |
$5.60 | -$14,000,000.00 | 20.46M |
Apr 5
| |||
Form 4
| -2.13% | -500.00K |
$10.07 | -$5,035,000.00 | 22.96M |
Dec 15
| |||
Form 4
| -5.63% | -1.40M |
$9.80 | -$13,720,000.00 | 23.46M |
Dec 7
| |||
Form 4
| -0.59% | -295.04K |
$9.75 | -$2,879,551.00 | 49.71M |
Nov 22 - Nov 23
| |||
Form 4
| -7.37% | -2.00M |
$9.25 | -$18,500,000.00 | 25.15M |
Nov 3
| |||
Form 4
| -3.76% | -1.06M |
$9.59 | -$10,161,150.00 | 27.15M |
Oct 28 - Oct 29
| |||
Form 4
| +44.07% | 8.63M |
$10.00 |
—
| 28.21M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Morphic Holding, Inc. (MORF) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.82% | -17.16K |
$54.65 | -$937,661.84 | 2.07M |
Scheduled
|
Apr 29 - Apr 30
| ||
Form 4
| -0.51% | -10.70K |
$55.42 | -$593,253.66 | 2.09M |
Scheduled
|
Apr 27 - Apr 28
| ||
Form 4
| -0.65% | -13.82K |
$56.00 | -$773,768.65 | 2.1M |
Scheduled
|
Apr 23 - Apr 26
| ||
Form 4
| -0.93% | -19.79K |
$57.07 | -$1,129,260.34 | 2.11M |
Scheduled
|
Apr 21 - Apr 22
| ||
Form 4
| -0.83% | -17.87K |
$54.30 | -$970,506.43 | 2.13M |
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
| -0.82% | -17.75K |
$55.62 | -$987,120.93 | 2.15M |
Scheduled
|
Apr 15 - Apr 16
| ||
Form 4
| -0.96% | -20.94K |
$57.49 | -$1,203,506.23 | 2.17M |
Scheduled
|
Apr 13 - Apr 14
| ||
Form 4
| -1.12% | -24.81K |
$58.00 | -$1,439,043.56 | 2.19M |
Scheduled
|
Apr 9 - Apr 12
| ||
Form 4
| -1.19% | -26.68K |
$60.79 | -$1,622,083.77 | 2.21M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| -0.90% | -20.42K |
$61.58 | -$1,257,689.69 | 2.24M |
Scheduled
|
Apr 5 - Apr 6
| ||
Form 4
| -1.33% | -30.41K |
$63.93 | -$1,943,933.67 | 2.26M |
Scheduled
|
Mar 31 - Apr 1
| ||
Form 4
| -1.55% | -36.08K |
$60.31 | -$2,175,567.05 | 2.29M |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
| -2.02% | -47.94K |
$58.67 | -$2,812,522.05 | 2.33M |
Scheduled
|
Mar 25 - Mar 26
| ||
Form 4
| -2.16% | -52.31K |
$60.52 | -$3,166,055.32 | 2.37M |
Scheduled
|
Mar 23 - Mar 24
| ||
Form 4
| -1.05% | -25.78K |
$63.96 | -$1,648,989.94 | 2.43M |
Scheduled
|
Mar 19 - Mar 22
| ||
Form 4
| -0.72% | -35.85K |
$64.07 | -$2,296,266.45 | 4.92M |
Scheduled
|
Mar 17 - Mar 18
| ||
Form 4
| -0.85% | -64.39K |
$65.95 | -$4,190,471.44 | 7.52M |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
| -1.39% | -35.99K |
$36.70 | -$1,320,706.83 | 2.55M |
Scheduled
|
Feb 25 - Mar 1
| ||
Form 4
| -0.41% | -10.55K |
$34.16 | -$360,312.90 | 2.59M |
Scheduled
|
Feb 23 - Feb 24
| ||
Form 4
| -0.42% | -10.86K |
$35.18 | -$382,043.62 | 2.6M |
Scheduled
|
Feb 19 - Feb 22
| ||
Form 4
| -0.62% | -16.16K |
$35.38 | -$571,564.72 | 2.61M |
Scheduled
|
Feb 17 - Feb 18
| ||
Form 4
| -0.32% | -8.39K |
$36.90 | -$309,548.28 | 2.63M |
Scheduled
|
Feb 12 - Feb 16
| ||
Form 4
| -0.38% | -10.07K |
$37.63 | -$379,016.26 | 2.63M |
Scheduled
|
Feb 10 - Feb 11
| ||
Form 4
| -0.83% | -22.08K |
$39.65 | -$875,693.86 | 2.64M |
Scheduled
|
Feb 8 - Feb 9
| ||
Form 4
| -0.57% | -15.42K |
$38.08 | -$587,182.27 | 2.67M |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
| -1.97% | -54.12K |
$37.05 | -$2,005,517.05 | 2.69M |
Scheduled
|
Feb 2 - Feb 3
| ||
Form 4
| -0.74% | -20.54K |
$33.73 | -$692,922.86 | 2.74M |
Scheduled
|
Jan 29 - Feb 1
| ||
Form 4
| -0.74% | -20.74K |
$32.77 | -$679,529.64 | 2.76M |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
| -0.28% | -15.91K |
$32.28 | -$506,503.22 | 5.57M |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
| -0.36% | -10.01K |
$30.74 | -$307,524.82 | 2.8M |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
| -0.61% | -17.24K |
$30.04 | -$517,887.90 | 2.81M |
Scheduled
|
Jan 19
| ||
Form 4
| -0.41% | -23.53K |
$30.44 | -$718,480.84 | 5.68M |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
| -0.44% | -12.50K |
$30.11 | -$376,257.20 | 2.85M |
Scheduled
|
Jan 12 - Jan 13
| ||
Form 4
| -0.43% | -12.41K |
$30.14 | -$373,950.81 | 2.86M |
Scheduled
|
Jan 8 - Jan 11
| ||
Form 4
| -0.97% | -28.16K |
$30.03 | -$845,829.99 | 2.88M |
Scheduled
|
Jan 6 - Jan 7
| ||
Form 4
| -0.87% | -25.44K |
$31.85 | -$810,393.44 | 2.9M |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| -0.54% | -15.89K |
$33.01 | -$524,573.06 | 2.93M |
Scheduled
|
Dec 30 - Dec 31
| ||
Form 4
| -0.67% | -19.89K |
$32.04 | -$637,415.51 | 2.95M |
Scheduled
|
Dec 28 - Dec 29
| ||
Form 4
| -0.40% | -12.03K |
$33.21 | -$399,381.61 | 2.97M |
Scheduled
|
Dec 23 - Dec 24
| ||
Form 4
|
∞
| 2.97M |
$15.00 |
—
| 2.97M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IMMUNIC, INC. (IMUX) Snapshot price: $1.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.73% | -183.61K |
$21.96 | -$4,032,560.54 | 6.55M |
Sep 20
| |||
Form 4
| -1.21% | -82.21K |
$21.75 | -$1,787,758.35 | 6.74M |
Sep 16 - Sep 18
| |||
Form 4
| -1.63% | -112.78K |
$21.22 | -$2,393,494.51 | 6.82M |
Sep 10 - Sep 11
| |||
Form 4
| -0.31% | -21.40K |
$21.56 | -$461,537.42 | 6.93M |
Sep 5 - Sep 6
| |||
Form 4
|
∞
| 6.95M |
—
|
—
| 6.95M |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +19,530.27% | 3.8M |
$17.72 |
—
| 3.82M |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |